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Abstract
Objectives: Stress and anxiety are controversial factors involved in the complex pathogenesis of Recurrent Aph-
thous Stomatitis (RAS). The determination of salivary cortisol is a useful, simple and safe test to detect states of 
high stress or anxiety. The aim of this study is to check for changes in salivary cortisol levels in patients with RAS 
during periods of active disease. 
Study design: A measurement of cortisol employing Enzyme-Linked Immuno Sorbent Assay (ELISA) was car-
ried out in samples of unstimulated saliva from 20 patients with active lesions of RAS and 10 healthy individuals 
used as controls. 
Results: Increased levels of salivary cortisol were detected in 3 cases, all of them within the group of patients with 
RAS. In none of the control group patients the level of salivary cortisol was increased. The mean level of salivary 
cortisol was 0.64 mg / dl (range 0.2 to 1.62) for patients with RAS and 0.57 mg / dl (range 0.25 to 1.09) for controls. 
Conclusion: Salivary cortisol levels are not statistically higher in patients with active lesions of RAS.
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Introduction
Recurrent Aphthous Stomatitis (RAS) is one of the most 
common diseases of the oral mucosa (1). However, the 
pathogenesis of RAS is not yet completely understood 
despite its high frequency. RAS is also one of oral dis-
eases on which more research work has been published 
in the medical literature (1). There is much controversy 
on its complex pathogenesis, with conflicting opinions 
between different groups of researchers (1.2). Many dif-
ferent factors such as genetic, immunological, micro-
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biological, nutritional, hormonal, emotional, traumatic 
and others are involved in the etiology of RAS. Unfor-
tunately, there is still no clear and definitive explana-
tion about how all these factors are really implied in the 
pathogenesis of RAS (1,2). 
Cortisol is the most abundant circulating steroid and 
the major glucocorticoid secreted by the adrenal cortex 
(3.4). Cortisol is involved in gluconeogenesis, calcium 
absorption and secretion of gastric acid and pepsin. 
Furthermore, it has an active role in the inflammatory 
response and in the regulation of blood pressure (3,4). 
The measurement of cortisol levels is also considered 
as a good indicator of adrenocortical function. Because 
of this, it is very useful in the diagnosis of Addison’s 
disease and Cushing, hypopituitarism and adrenal hy-
perplasia and carcinoma (3.4). Cortisol levels are abnor-
mally increased in situations of pain, stress, acute infec-
tions, diabetes mellitus, heart failure, pregnancy and in 
patients under estrogen therapy (3.4). 
Close correlations between serum and salivary levels of 
cortisol have been demonstrated in different studies (5.6). 
Therefore, salivary cortisol determination is currently 
considered a reliable indicator of adrenal function.
There are several processes that can modify the concentra-
tion of salivary cortisol. Some of them, such as depressive 
states can make it fall. However, others such as stress or 
anxiety states can increase it (7.8). Interestingly, patients 
with RAS often relate the onset of new lesions with what 
they recognize as “periods of increased stress or anxiety”.
Several authors (9-12) have studied the salivary levels 
of this glucocorticoid in different oral conditions such 
as lichen planus, xerostomia, periodontal disease and 
RAS, with no conclusive results obtained to date.
The aim of this study is to check if salivary cortisol lev-
els are higher in patients with RAS during periods of 
active disease than in healthy individuals. 
Material and Methods
A prospective observational pilot study was performed 
on 20 patients with RAS selected by simple randomiza-
tion (using tables of random numbers) from a group of 
patients previously diagnosed with RAS in the Service 
of Oral Medicine of the Dentistry Clinic of The Uni-
versity of the Basque Country / EHU. All the patients 
in this group attended regularly to control reviews and 
met the inclusion and exclusion criteria of RAS. Sali-
vary samples were collected during the years 2007 and 
2008, always during the presence of active lesions in 
ulcerative phase.
The study group was composed of 12 women (60%) and 
8 men (40%) with a mean age of 35.9 years (mean devia-
tion: ± 14.2, range: 21-67).
The control group consisted of 10 healthy individuals liv-
ing in the Basque Country without RAS, 5 men and 5 
women, with a mean age of 36.6 years (mean deviation: ± 
11.9, range: 20-56). These patients were selected by sim-
ple randomization (with random number tables) from a 
group of people attending a dental check to the Dental 
Clinic of the University during the same period of time.
The criteria for inclusion in the group of patients with 
RAS were lived in the Basque Country and had a clear 
diagnosis of the disease, fulfilling the clinical charac-
teristics that typically define the RAS (1,2).
Patients with severe systemic disease or immunode-
ficiency, endocrine or metabolic disease, and patients 
with other concomitant oral diseases were excluded 
from the study. Patients with inconclusive diagnosis of 
RAS were also excluded.
Unstimulated salivary samples were collected from all 
patients after carrying out a detailed medical history. 
Previously, the informed consent was obtained from all 
the patients. Salivary samples were collected asking the 
patients to deposit all their saliva into a test tube for five 
minutes (13). All of the samples were collected between 
9 and 12 AM to minimize the effect of thecircadian cy-
cle. In every case it was performed one hour and a half 
after awakening or food intake.
Salivary samples were frozen at -25 ° C temperature and 
stored, after cooling to room temperature for 10 minutes.
The measurement of salivary cortisol was obtained by 
Enzyme Linked Inmunosorbent Assay (ELISA) using 
the Immulite 2000 Cortisol® test (Diagnostic Product 
Corporation, Dipesa SA, Spain).  The Automated Im-
mulite 2000® analysis unit (Diagnostic Product Corpo-
ration, Dipesa SA, Spain) was used to get a spectropho-
tometric analysis. Normal reference range was consid-
ered to be between 0.18 and 1.20 mg / dl (13).
After this, a descriptive and comparative statistical 
analysis was performed with the obtained results. 
The two-tailed Student s´ t test for independent sam-
ples with a confidence level of 99% (α, 0.01) and 95% 
(α, 0.05) was employed in the analysis of quantitative 
variables.
Results
All the patients in the study group had suffered at least 
10 minor type aphthous lesions during the last year be-
fore the study. Thirteen patients (65%) suffered lesions 
almost continuously and without remissions. In 5 pa-
tients (25%), the periods free of lesions lasted from 1 to 
3 months and only in 2 patients (10%) the periods lasted 
for more than 3 months. The most common locations for 
the lesions were the tongue (75%), buccal mucosa (70%) 
and labial mucosa (60%).
In relation to the triggers, 8 patients (40%) related hav-
ing a significant increase in the number of ulcers during 
the periods in which they recognized having suffered 
situations of increased stress or anxiety.
Only 3 patients of RAS group (15%) presented increased 
levels of salivary cortisol. 
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None of the patients in the control group presented in-
creased levels of salivary cortisol. The mean cortisol 
level was 0.64 mg / dl (mean deviation ± 0.36, range 0.2 
to 1.62) for patients with RAS and 0.57 mg / dl (mean 
deviation ± 0 , 25, range from 0.25 to 1.09) for controls 
(Table 1). After the statistical analysis, salivary cortisol 
levels were not statistically higher in patients with RAS 
(Fig. 1).
Discussion
It is well-known that some oral diseases may have a psy-
chosomatic component (14). In RAS stress or anxiety, 
could act as precipitating factor causing the develop-
ment of new lesions (1,2,9). The real role of this factor 
is still unknown but it can be probably related with the 
modifications that anxiety and stress produce in the oral 
mucosa, the increase of the parafunctional habits or the 
increase in some habits that causes microtraumatic in-
juries (1,2,9).
As a result, Soto-Araya and cols. (15) studied the 
prevalence and degree of stress, anxiety and depres-
sion among patients with different oral diseases such as 
burning mouth syndrome, oral lichen planus and RAS. 
Using the Recent experience test and the HAD scale 
(Hospital Anxiety scale and depression), they found in-
creased levels of stress (61%) and anxiety (83%) among 
the 18 patients with RAS of their study group.
Later, Gallo and cols. (16) studied the stress levels 
through the questionnaire SSLVAS (Symptoms of Stress 
List, Institute of Psychology at the University of Sao 
Paulo, Brasil) in 55 patients with RAS and 25 healthy 
patients. Soto-Araya and cols. observed a significantly 
higher level of stress among patients with RAS too. 
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Fig. 1. Salivary cortisol levels in patients with recurrent aphthous stomatitis (RAS) and controls.
RAS patients&Controls Cortisol (µg/dl)
Sample 1 0,42 
Sample 2 0,71 
Sample 3 0,44 
Sample 4 0,44 
Sample 5 1,25 
Sample 6 1,28 
Sample 7 0,85 
Sample 8 0,33 
Sample 9 0,37 
Sample 10 0,68 
Sample 11 0,62 
Sample 12 1,62 
Sample 13 0,64 
Sample 14 0,46 
Sample 15 0,2 
Sample 16 0,51 
Sample 17 0,56 
Sample 18 0,39 
Sample 19 0,67 
Sample 20 0,31 
Control 1 0,53 
Control 2 0,92 
Control 3 0,56 
Control 4 1,09 
Control 5 0,25 
Control 6 0,45 
Control 7 0,50 
Control 8 0,41 
Control 9 0,44 
Control 10 0,53 
Table 1. Results of the measurement of salivary cortisol 
levels in patients with recurrent aphthous stomatitis (RAS) 
and control patients.
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However, they observed no statistically significant re-
lationship between the clinical severity of RAS lesions 
and stress level.
Salivary cortisol has been shown in several studies (17,18) 
as a safe analytic tool, useful for detecting high stress or 
anxiety states. The production of cortisol by the adrenal 
glands is controlled by the secretion of the adrenocor-
ticotropic hormone (ACTH) from the pituitary gland. 
ACTH secretion is regulated by the action of corticotro-
pin releasing hormone (CRH), a hypothalamic hormone, 
which is stimulated by stress situations (15-18). Under 
normal conditions the secretion of ACTH is rhythmi-
cally produced synchronized with the sleep-wake cycle, 
so the secretion is maximal in the morning and minimal 
at midnight.This variation is known as circadian rhythm 
or cycle, and it allows us to maintain a high activity level 
during the day in contrast to the night.
Anxiety and depression states not only modify the 
physiological production of cortisol and its concentra-
tion in plasma, it also produces a proportional change in 
the concentration of cortisol in saliva (16,17).
In 1996 McCartan and cols. (9), compared the levels of 
salivary cortisol by radioimmunoassay, and the degree 
of anxiety by the HAD psychometric scale, between 
two different groups of patients with RAS. In the first 
group they included 12 patients with persistent oral le-
sions, no hematological alterations and no improvement 
in symptoms after oral empirical administration of vi-
tamin B1 and B6. In a second group they included other 
12 patients who had improved their oral symptoms after 
correcting hematological deficiencies, such as deficits 
of iron or vitamin B12. In this second group they also 
included patients who had had a positive response after 
empirical administration of vitamin B1 and B6. After 
a statistical analysis, they found a significantly higher 
level of anxiety and salivary cortisol among the patients 
in the first study group.
Later, Albanidou-Farmaki and cols. (19) also studied 
the possible association between anxiety, serum and 
salivary cortisol, and RAS. They selected a group of 38 
patients with RAS and a control group of 38 healthy pa-
tients and carried out a determination of cortisol using 
chemiluminescent immunoassay. To determine the de-
gree of anxiety they used a test consisting of two inde-
pendent scales, one for the “Status Anxiety” (STAI-S) 
and other one for the “Trait Anxiety” (STAI-T).After 
analyzing the results they observed significantly higher 
cortisol levels, both in saliva and serum in the group of 
patients with RAS. Furthermore, levels of “trait anxi-
ety” and “status anxiety” were also significantly higher 
in RAS patients than in healthy individuals.
The determination of salivary cortisol is a widely con-
trasted method to measure and quantify situations or 
states of stress and anxiety (6,10,11). In opposition to 
these previous works that measured salivary cortisol in 
patients with RAS, our results in this pilot study have not 
shown a significant increase in salivary cortisol. We don t´ 
Know exactly what causes this difference, but we think 
they might be due to several reasons. The first one and 
the most obvious, is the limited sample size of the stud-
ies. Moreover, the populations studied are very different, 
have different epidemiological characteristics and might 
show differences in the prevalence of stress. In relation 
to the methodology employed, we do not know exactly 
how much could some of the important differences that 
we found have influenced in the results.
In our study, the saliva sample collection was per-
formed in all cases during the active phase of the dis-
ease and was always carried out in the morning between 
9 and 12 AM. We always collected unstimulated saliva. 
In the study of Albanidou-Farmaki and cols. (18), we 
don t´ know if the patients had active lesions at the time 
of sample collection. In their study the samples were 
collected from stimulated saliva (with 10% citric acid) 
and inclusion and exclusion criteria of patients were dif-
ferent. Processing and technical methods and materials 
used by them were different too.
In the study of McCartan and cols. (9), sample collec-
tion was performed between 1 and 2 PM and using sa-
liva stimulated with a 10% citric acid solution. While 
in their first group of the study samples were collected 
during the active phase of the disease in the second it is 
unclear. We can conclude reading their article that they 
collected the samples in this second group in patients 
free of lesions at that moment. In this study, inclusion 
criteria and processing methods and materials used 
were different from ours too.
Although our overall results do not show a significant 
increase of salivary cortisol, we found that patients with 
the higher salivary cortisol concentrations suffered 
more severe clinical forms of the disease, according to 
the number, size and recurrence of lesions.
As a conclusion of this pilot study we can remark that 
we could not observe the existence of significantly high-
er salivary cortisol levels among the patients with RAS 
in our region during periods of active disease than in 
healthy individuals.
Due to the differences observed between our results and 
those obtained by other authors, we believe that further 
studies are needed in other populations with larger sam-
ple sizes. In this way we will be able to determine the real 
role of salivary cortisol and the real importance of stress 
and anxiety as triggers in the pathogenesis of the RAS.
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